Citigroup reiterated its Neutral on Bed Bath & Beyond BBBY and raised its price target from $70 to $74.
Citigroup noted, "We believe 2Q results could be viewed as disappointing as: 1) SSS on a 2 year stack continues to slide (-90bps Q/Q), and 2) GM% decline of -127bps Y/Y. We expect gross margins to continue to be under pressure from the more targeted couponing strategy and from the mix impact from Cost Plus. … We are actually raising our estimates for FY13 based on the accretion of the Cost Plus acquisition to $4.56, up from $4.45. Our FY14 estimate goes to $5.30, up from $5.00. Our target price goes to $74."
Bed Bath & Beyond closed at $68.79 on Thursday.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in